The DOI matches its Crossref record; 111 of the 112 references it cites were found in a registry or an index.
From Chronic Cerebral Hypoperfusion to Alzheimer-Like Brain Pathology and Neurodegeneration
Open accessAbstract
Chronic cerebral hypoperfusion (CCH) is a common consequence of various cerebral vascular disorders and hemodynamic and blood changes. Recent studies have revealed an important role of CCH in neurodegeneration and dementia, including vascular dementia and Alzheimer's disease (AD). This article reviews the recent advances in understanding CCH-induced neurodegeneration and AD-related brain pathology and cognitive impairment. We discuss the causes and assessment of CCH, the possible mechanisms by which CCH promotes Alzheimer-like pathology and neurodegeneration, and animal models of CCH. It appears that CCH promotes neurodegeneration and AD through multiple mechanisms, including induction of oxidative stress, Aβ accumulation and aggravation, tau hyperphosphorylation, synaptic dysfunction, neuronal loss, white matter lesion, and neuroinflammation. Better understanding of the mechanisms of CCH will help develop therapeutic strategies for preventing and treating neurodegeneration, including sporadic AD and vascular dementia, caused by CCH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CBH during ageing has been widely reported to contribute to AD pathogenesis.210”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [210]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Ye, X., Wang, M., Zhang, W., Bai, M., Du, Y., Zhang, Z., Li, Z., & Miao, J. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.11.016 · Cited by 72
RetractedRETRACTED: Evaluation of Antiphospholipid Antibodies in Youths Suffering from Cerebral Ischemia
Goldust, M., Talebi, M., Majidi, J., Saatlou, M. A. R., & Rezaee, E. (2012) · International Journal of Neuroscience · doi:10.3109/00207454.2012.749256 · Cited by 27
RetractedAharoni, S. M. (2008) · International Journal of Polymeric Materials · doi:10.1080/00914030802541591 · Cited by 15
RetractedLyons, K., & Pahwa, R. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.783433 · Cited by 1
RetractedNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 2×
“Ab pathological deposition occurs both in the brain parenchyma and in the vascular structure in AD brain and in the brains of transgenic animal models with APP mutations (Games et al. 1995; Hsiao et al. 1996 Ab deposition that is somewhat different from the mature Ab plaques seen in AD brain.”
Cited by
Gut microbiota and dysbiosis in Alzheimer's disease: Implications for pathogenesis and treatment
Liu, S., Gao, J., Zhu, M., Liu, K., & Zhang, H.-L. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02073-3 · Cited by 516
“Extensive research argues mitochondrial dysfunction [13], insulin resistance (IR) [14], and cerebral hypoperfusion [15] may mediate, drive, or possibly even initiate pathologic molecular cascades in AD and finally promote Aβ accumulation, tau hyperphosphorylation, synaptic degeneration, and neuronal dysfunction.”
BackgroundRole of microbiota-derived short-chain fatty acids in nervous system disorders
Mirzaei, R., Bouzari, B., Hosseini-Fard, S. R., Mazaheri, M., Ahmadyousefi, Y., Abdi, M., Jalalifar, S., Karimitabar, Z., Teimoori, A., Keyvani, H., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111661 · Cited by 386
The biological pathways of Alzheimer disease: a review
Calabrò, M., Department of Biomedical and Dental Sciences and Morphofunctional Imaging, U. O. M., Rinaldi, C., Santoro, G., & Crisafulli, C. (2021) · AIMS Neuroscience · doi:10.3934/neuroscience.2021005 · Cited by 265
Xiao, W., Su, J., Gao, X., Yang, H., Weng, R., Ni, W., & Gu, Y. (2022) · Microbiome · doi:10.1186/s40168-022-01255-6 · Cited by 252
“CCH incurs negative impacts like oxidative stress, neuroinflammation, mitochondrial dysfunction, and metabolic dysfunction, aggravating brain injury insidiously [73, 74].”
BackgroundLiu, J., Sun, J., Wang, F., Yu, X., Ling, Z., Li, H., Zhang, H., Jin, J., Chen, W., Pang, M., et al. (2015) · BioMed Research International · doi:10.1155/2015/412946 · Cited by 225
“Clinical evidence supports that chronic cerebral hypoperfusion is associated with cognitive decline and hippocampal neuronal injury in neurodegenerative disorders [2, 3].”
Background
Metadata
- Authors
- Zhao, Y., & Gong, C.-X.
- Corresponding author
- Gong, Cheng-Xin
- ORCID
- Gong, Cheng-Xin
- Venue
- Cellular and Molecular Neurobiology
- Published
- 2014-10-29
- Volume
- 35
- Issue
- 1
- Pages
- 101-110
- ISSN
- 0272-4340 (ISSN-L)
- 1573-6830
- PMC
- PMC11486181
- OpenAlex
- W2018304868
- Cited by
- 180
- References
- 112
- Citations by year
- 2026: 13 · 2025: 27 · 2024: 15 · 2023: 18 · 2022: 21 · 2021: 13 · 2020: 19 · 2019: 18 · 2018: 10 · 2017: 10 · 2016: 5 · 2015: 11
- FWCI
- 0.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cellular and Molecular Neurobiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Office for People With Developmental Disabilities
- Topics
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- chronic cerebral hypoperfusion, Alzheimer's disease, neurodegeneration, vascular dementia, dementia, oxidative stress, amyloid-beta deposition, tau hyperphosphorylation, synaptic dysfunction, white matter lesions, neuroinflammation, cognitive impairment
- MeSH terms
- Alzheimer Disease, Animals, Brain, Cerebrovascular Circulation, Humans, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: From Chronic Cerebral Hypoperfusion to Alzheimer-Like Brain Pathology and Neurodegeneration. https://app.cochat.ai/papers/10.1007/s10571-014-0127-9
- The paper
- Zhao, Y., & Gong, C.-X. (2015). From Chronic Cerebral Hypoperfusion to Alzheimer-Like Brain Pathology and Neurodegeneration. Cellular and Molecular Neurobiology. https://doi.org/10.1007/s10571-014-0127-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.